+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Insulin Delivery Devices - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • June 2021
  • Region: Global
  • GlobalData
  • ID: 5351441
Description Jump to:
The Medical Devices sector report, “Insulin Delivery Devices - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Insulin Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Insulin delivery devices are used to inject measured doses of insulin through the skin and into the fatty tissues below. Insulin delivery devices included in this category are insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Insulin Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Insulin Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Insulin Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Insulin Delivery Devices Overview
3 Products under Development
3.1 Insulin Delivery Devices - Pipeline Products by Stage of Development
3.2 Insulin Delivery Devices - Pipeline Products by Segment
3.3 Insulin Delivery Devices - Pipeline Products by Territory
3.4 Insulin Delivery Devices - Pipeline Products by Regulatory Path
3.5 Insulin Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Insulin Delivery Devices - Ongoing Clinical Trials
4 Insulin Delivery Devices - Pipeline Products under Development by Companies
4.1 Insulin Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Insulin Delivery Devices - Pipeline Products by Stage of Development
5 Insulin Delivery Devices Companies and Product Overview
5.1 Abbott Diabetes Care Inc Company Overview
5.1.1 Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aerami Therapeutics Inc Company Overview
5.2.1 Aerami Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Amrita Vishwa Vidyapeetham Company Overview
5.3.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview
5.4 Andain, Inc Company Overview
5.4.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Animas Corp Company Overview
5.5.1 Animas Corp Pipeline Products & Ongoing Clinical Trials Overview
5.6 ASTI Corp Company Overview
5.6.1 ASTI Corp Pipeline Products & Ongoing Clinical Trials Overview
5.7 Avecho Biotechnology Ltd Company Overview
5.7.1 Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Becton Dickinson and Co Company Overview
5.8.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
5.9 Bigfoot Biomedical Inc Company Overview
5.9.1 Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 Biocon Ltd Company Overview
5.10.1 Biocon Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.11 Cambridge Consultants Ltd Company Overview
5.11.1 Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 Capillary Biomedical, Inc. Company Overview
5.12.1 Capillary Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Cellnovo Ltd Company Overview
5.13.1 Cellnovo Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.14 CeQur SA Company Overview
5.14.1 CeQur SA Pipeline Products & Ongoing Clinical Trials Overview
5.15 Debiotech SA Company Overview
5.15.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
5.16 Defymed SAS Company Overview
5.16.1 Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
5.17 Dermisonics Inc (Inactive) Company Overview
5.17.1 Dermisonics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.18 Eli Lilly and Co Company Overview
5.18.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
5.19 Emperra GmbH E-Health Technologies Company Overview
5.19.1 Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.20 Hospira Inc Company Overview
5.20.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 Imagine Medical Device Inc. Company Overview
5.21.1 Imagine Medical Device Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.22 InsuLenz Company Overview
5.22.1 InsuLenz Pipeline Products & Ongoing Clinical Trials Overview
5.23 Insulet Corp Company Overview
5.23.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
5.24 InsuLine Medical Ltd Company Overview
5.24.1 InsuLine Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 Iowa State University Company Overview
5.25.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
5.26 LifeScan Inc Company Overview
5.26.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 MannKind Corp Company Overview
5.27.1 MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
5.28 Medical International Technologies (Mit Canada) Inc Company Overview
5.28.1 Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 Medicsensors SL Company Overview
5.29.1 Medicsensors SL Pipeline Products & Ongoing Clinical Trials Overview
5.30 MedPro Safety Products, Inc. Company Overview
5.30.1 MedPro Safety Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.31 MedSolve Technologies, Inc. Company Overview
5.31.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.32 Medtronic Diabetes Company Overview
5.32.1 Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
5.33 Medtronic Plc Company Overview
5.33.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.34 MicroPort Scientific Corp Company Overview
5.34.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.35 Modular Medical Inc Company Overview
5.35.1 Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.36 NanoDerma Ltd Company Overview
5.36.1 NanoDerma Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.37 nGageIT Digital Health Inc Company Overview
5.37.1 nGageIT Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.38 Nitto Denko Corp Company Overview
5.38.1 Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview
5.39 North Carolina State University Company Overview
5.39.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
5.40 Novo Nordisk AS Company Overview
5.40.1 Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview
5.41 Pennsylvania State University Company Overview
5.41.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview
5.42 Phluid Corporation Company Overview
5.42.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.43 PhysioLogic Devices Inc Company Overview
5.43.1 PhysioLogic Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.44 Prometheon Pharma LLC Company Overview
5.44.1 Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
5.45 Qlibrium Inc Company Overview
5.45.1 Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview
5.46 Sanofi Company Overview
5.46.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview
5.47 SFC Fluidics LLC Company Overview
5.47.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.48 Sooil Development Co., Ltd. Company Overview
5.48.1 Sooil Development Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.49 Spring Health Solutions Ltd. Company Overview
5.49.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.50 Tandem Diabetes Care Inc Company Overview
5.50.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
5.51 Thermalin Inc Company Overview
5.51.1 Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview
5.52 Transdermal Specialties Inc Company Overview
5.52.1 Transdermal Specialties Inc Pipeline Products & Ongoing Clinical Trials Overview
5.53 Triple Jump Israel Ltd Company Overview
5.53.1 Triple Jump Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.54 University of KwaZulu-Natal Company Overview
5.54.1 University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview
5.55 University of Missouri-Kansas City Company Overview
5.55.1 University of Missouri-Kansas City Pipeline Products & Ongoing Clinical Trials Overview
5.56 University of North Carolina Company Overview
5.56.1 University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview
5.57 University of Toronto Company Overview
5.57.1 University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
5.58 Univlabs Technologies Pvt Ltd Company Overview
5.58.1 Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.59 Valeritas Inc Company Overview
5.59.1 Valeritas Inc Pipeline Products & Ongoing Clinical Trials Overview
5.60 ViCentra BV Company Overview
5.60.1 ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview
5.61 Vigmed Holding AB Company Overview
5.61.1 Vigmed Holding AB Pipeline Products & Ongoing Clinical Trials Overview
5.62 Ypsomed Holding AG Company Overview
5.62.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
5.63 Zealand Pharma AS Company Overview
5.63.1 Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview
5.64 Zenomics Inc Company Overview
5.64.1 Zenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Insulin Delivery Devices- Recent Developments
6.1 Jun 04, 2021: AstraZeneca appoints Aradhana Sarin as new Chief Financial Officer
6.2 May 26, 2021: Bayer joins Greentown Labs' Corporate Partner Network
6.3 May 17, 2021: Retractable Technologies Reports $23.4 Million in Operating Income for First Quarter Of 2021
6.4 May 06, 2021: Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial
6.5 May 06, 2021: Nektar Therapeutics Reports First Quarter 2021 Financial Results
6.6 May 06, 2021: Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year
6.7 May 05, 2021: Lilly to Participate in Bank of America Securities 2021 Health Care Conference
6.8 Apr 30, 2021: AstraZeneca announce First quarter 2021 results 30 April 2021
6.9 Apr 29, 2021: Integer Holdings Reports First Quarter 2021 Results
6.10 Apr 21, 2021: F. Hoffman La Roche's sales performance for the first quarter of 2021
6.11 Apr 15, 2021: Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22
6.12 Apr 06, 2021: NYU Abu Dhabi researchers develop materials for oral delivery of insulin medication
6.13 Apr 05, 2021: Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021
6.14 Apr 05, 2021: BD To Announce Financial Results For Its Second Quarter Of Fiscal 2021
6.15 Apr 04, 2021: Hindustan Syringes and Medical Devices (HMD)to invest over 100 crore to ramp up syringe production
6.16 Apr 01, 2021: Integer Schedules First Quarter 2021 Earnings Release and Conference Call for April 29, 2021
6.17 Mar 29, 2021: Stevanato Group to participate at World Vaccine Congress Washington
6.18 Mar 26, 2021: Smiths Medical announces recall of Medex High Pressure Adaptors, Rotators, Manifolds, Stopcocks and Tubing, and LogiCal Kits
6.19 Mar 25, 2021: Correction: Resolutions from the Annual General Meeting of Novo Nordisk A/S
6.20 Mar 19, 2021: BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management
6.21 Mar 16, 2021: Modular Medical relocates to larger corporate headquarters
6.22 Mar 10, 2021: MannKind Corporation to Participate in Oppenheimer's 31st Annual Healthcare Conference
6.23 Mar 02, 2021: Biocon Biologics Appoints Susheel Umesh as Chief Commercial Officer for Emerging Markets
6.24 Mar 02, 2021: MannKind to Participate in H.C. Wainwright Global Life Sciences Conference
6.25 Feb 22, 2021: Franco Moro appointed Chief Executive Officer of Stevanato Group, Franco Stevanato becomes Executive Chairman
6.26 Feb 18, 2021: Integer Holdings Reports Results for Fourth Quarter and Full Year 2020
6.27 Feb 18, 2021: MannKind to Hold 2020 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2021
6.28 Feb 18, 2021: Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2020 on Thursday, February 25, 2021
6.29 Feb 18, 2021: MannKind Corporation to Participate in 2021 SVB Leerink Global Healthcare Conference
6.30 Feb 18, 2021: Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2020 on Thursday, February 25, 2021, After Close of U.S.-Based Financial Markets
6.31 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.32 Feb 16, 2021: Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations
6.33 Feb 11, 2021: AstraZeneca announces Full-year 2020 results 11 February 2021
6.34 Feb 02, 2021: Pfizer Reports Mixed Q4 Results
6.35 Feb 01, 2021: Girls Inc. Of Chattanooga Appoints Toccora Johnson As New CEO
6.36 Feb 01, 2021: Integer Appoints Sheila Antrum, Cheryl Capps and Tyrone Jeffers to Board of Directors
6.37 Jan 15, 2021: Integer Schedules Fourth Quarter and Full-Year 2020 Earnings Release and Conference Call for February 18, 2021
6.38 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings
6.39 Jan 04, 2021: MannKind to Participate in H.C. Wainwright Bioconnect 2021 Conference
6.40 Jan 04, 2021: Ypsomed reaches agreement in legal dispute with Insulet
6.41 Dec 18, 2020: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
6.42 Dec 11, 2020: Roche teams up with Diabeloop to advance the management of insulin pump therapy
6.43 Dec 09, 2020: Sanofi pioneers sustainable finance in the pharmaceutical industry with the signing of its two first sustainability-linked revolving credit facilities
6.44 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
6.45 Oct 20, 2020: Insulet appoints Wayne A. I. Frederick, M.D., to Board of Directors
6.46 Oct 02, 2020: Hindustan Syringes and Medical Devices ships over 56m syringes to Covax facility
6.47 Sep 10, 2020: Lilly commits Insulin Value Program, featuring $35 copay card, to suite of affordability solutions for people with diabetes
6.48 Sep 08, 2020: Penn Researchers make major advancement in Islet Cell Transplantation for treating Type-1 diabetes
6.49 Aug 20, 2020: Progress update for TPM cannabinoid development program
6.50 Aug 14, 2020: Novo Nordisk invests DKK 850 million in production facilities in Kalundborg
6.51 Aug 12, 2020: Medtronic to acquire insulin pen maker Companion Medical
6.52 Aug 06, 2020: Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020
6.53 Jul 30, 2020: Tandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020
6.54 Jul 27, 2020: Roche contract expansion to profile autoantibodies
6.55 Jul 17, 2020: Lilly Confirms Date and Conference Call for Second-Quarter 2020 Financial Results Announcement
6.56 Jul 09, 2020: ViCentra raises fresh funds to boost insulin pump production capacity
6.57 Jul 08, 2020: Retractable Technologies provides update on its Technology Investment Agreement
6.58 Jun 25, 2020: Integer Opens New Innovative Ireland Research and Development Facility
6.59 Jun 15, 2020: MicroPort announces strategic investment and forms joint venture with Indian medical device company purple medical
6.60 Jun 15, 2020: Aradigm announces effective date of modified combined Chapter 11 Plan and disclosure statement
6.61 Jun 15, 2020: Bayer U.S announces retirement of Philip Blake
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Insulin Delivery Devices - Pipeline Products by Stage of Development
  • Insulin Delivery Devices - Pipeline Products by Segment
  • Insulin Delivery Devices - Pipeline Products by Territory
  • Insulin Delivery Devices - Pipeline Products by Regulatory Path
  • Insulin Delivery Devices - Pipeline Products by Estimated Approval Date
  • Insulin Delivery Devices - Ongoing Clinical Trials
  • Insulin Delivery Devices Companies - Pipeline Products by Stage of Development
  • Insulin Delivery Devices - Pipeline Products by Stage of Development
  • Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Freestyle Libre Connected Insulin Pen - Product Status
  • Freestyle Libre Connected Insulin Pen - Product Description
  • Aerami Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Dance-501 - Product Status
  • Dance-501 - Product Description
  • Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview
  • Amrita Insulin Pump - Product Status
  • Amrita Insulin Pump - Product Description
  • Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Gaia Med Diamond Semi-Disposable Pump - Product Status
  • Gaia Med Diamond Semi-Disposable Pump - Product Description
  • Gemini Pump - Product Status
  • Gemini Pump - Product Description
  • Animas Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Hypoglycemia-Hyperglycemia Minimizer System - Product Status
  • Hypoglycemia-Hyperglycemia Minimizer System - Product Description
  • ASTI Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Plastic Microneedle System - Product Status
  • Plastic Microneedle System - Product Description
  • Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • TPM-Insulin Patch - Product Status
  • TPM-Insulin Patch - Product Description
  • Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
  • Extended Wear Insulin Infusion Set - Product Status
  • Extended Wear Insulin Infusion Set - Product Description
  • Type 2 Patch Pump - Product Status
  • Type 2 Patch Pump - Product Description
  • Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Bigfoot Unity - Product Status
  • Bigfoot Unity - Product Description
  • Biocon Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Semglee Prefilled Pen - Product Status
  • Semglee Prefilled Pen - Product Description
  • Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • KiCoPen - Product Status
  • KiCoPen - Product Description
  • Capillary Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • CSII Catheter - Product Status
  • CSII Catheter - Product Description
  • SteadiSet Infusion Set - Product Status
  • SteadiSet Infusion Set - Product Description
  • Capillary Biomedical, Inc. - Ongoing Clinical Trials Overview
  • CSII Catheter - A Pilot Study for the Systematic Evaluation of the Inflammatory Response to Commercially Available Insulin Infusion Catheters in Subcutaneous Adipose Tissue
  • SteadiSet Infusion Set - Open, Controlled, and Randomized Cross-over Pilot Study of an Investigational Extended Wear Insulin Infusion Set During Home Use in People with Type 1 Diabetes Mellitus
  • SteadiSet Infusion Set - Randomized Crossover Euglycemic Clamp Study in Adult Patients with Type 1 Diabetes to Assess Pharmacokinetics and Pharmacodynamics of Subcutaneously Infused Insulin Using an Investigational Extended Wear Continuous Subcutaneous Insulin Infusion Cannula Compared to a Commercial Infusion Set
  • Cellnovo Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Wireless Insulin Pump System Integrated With inControl AP - Product Status
  • Wireless Insulin Pump System Integrated With inControl AP - Product Description
  • CeQur SA Pipeline Products & Ongoing Clinical Trials Overview
  • CeQur Simplicity - Product Status
  • CeQur Simplicity - Product Description
  • Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
  • JewelPump - Product Status
  • JewelPump - Product Description
  • JewelPUMP2 - Product Status
  • JewelPUMP2 - Product Description
  • Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
  • ExOlin - Product Status
  • ExOlin - Product Description
  • Dermisonics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • U-Strip - Product Status
  • U-Strip - Product Description
  • Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview
  • AID System - Product Status
  • AID System - Product Description
  • AIR Insulin System - Product Status
  • AIR Insulin System - Product Description
  • BASAGLAR Tempo Pen - Product Status
  • BASAGLAR Tempo Pen - Product Description
  • Connected Care Prefilled Insulin Pen - Product Status
  • Connected Care Prefilled Insulin Pen - Product Description
  • Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • ESYSTA BT Pen - Product Status
  • ESYSTA BT Pen - Product Description
  • Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Integrated Symbiq/EndoTool System - Product Status
  • Integrated Symbiq/EndoTool System - Product Description
  • Imagine Medical Device Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Insulin Syringe - Product Status
  • Insulin Syringe - Product Description
  • InsuLenz Pipeline Products & Ongoing Clinical Trials Overview
  • Smart Polymer Contact Lens - Product Status
  • Smart Polymer Contact Lens - Product Description
  • Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Omnipod U-200 Insulin Management System - Product Status
  • Omnipod U-200 Insulin Management System - Product Description
  • Omnipod U-500 Insulin Management System - Product Status
  • Omnipod U-500 Insulin Management System - Product Description
  • InsuLine Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Long Acting Insulin Therapy Device - Product Status
  • Long Acting Insulin Therapy Device - Product Description
  • Iowa State University Pipeline Products & Ongoing Clinical Trials Overview
  • Feed Forward Insulin Delivery Devices System - Product Status
  • Feed Forward Insulin Delivery Devices System - Product Description
  • LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview
  • ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Status
  • ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Description
  • MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
  • AFREZZA - Medtone Inhaler - Product Status
  • AFREZZA - Medtone Inhaler - Product Description
  • Afrezza - Pediatric Use - Product Status
  • Afrezza - Pediatric Use - Product Description
  • MannKind Corp - Ongoing Clinical Trials Overview
  • AFREZZA - Medtone Inhaler - A-One: A Randomized Controlled Trial Evaluating One Drop - Premium with Afrezza versus One Drop - Premium Alone
  • AFREZZA - Medtone Inhaler - DOS [Dosing Optimization Study]: Open-label, Single-arm, Proof-of-concept Dosing Study of Afrezza in Adult Subjects 18 Years and Older with Type 1 or Type 2 Diabetes Mellitus
  • AFREZZA - Medtone Inhaler - Improving Post-prandial Blood Glucose Control with Afrezza During Closed-loop Therapy
  • AFREZZA - Medtone Inhaler - Study Comparing Prandial Insulin Aspart Vs. Technosphere Insulin in Patients with Type 1 Diabetes on Multiple Daily Injections: Investigator-initiated a Real-life Pilot Study-STAT Study
  • Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Med-Jet MIT-P-I - Product Status
  • Med-Jet MIT-P-I - Product Description
  • Medicsensors SL Pipeline Products & Ongoing Clinical Trials Overview
  • Insulin Smartpatch - Product Status
  • Insulin Smartpatch - Product Description
  • MedPro Safety Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Insulin Guard Self-Injector Safety Needle - Product Status
  • Insulin Guard Self-Injector Safety Needle - Product Description
  • MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Freehand Patch Pump - Product Status
  • Freehand Patch Pump - Product Description
  • Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
  • Insulin Delivery Devices System - Product Status
  • Insulin Delivery Devices System - Product Description
  • MiniMed Extended Wear Infusion Set - Product Status
  • MiniMed Extended Wear Infusion Set - Product Description
  • MiniMed Mio Advance Infusion Set - Product Status
  • MiniMed Mio Advance Infusion Set - Product Description
  • Medtronic Diabetes - Ongoing Clinical Trials Overview
  • MiniMed Extended Wear Infusion Set - Evaluation of Extended Wear Infusion Set with 670G Hybrid Closed-Loop Therapy
  • Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
  • MiniMed 770G System - Product Status
  • MiniMed 770G System - Product Description
  • MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Angel Touch - Product Status
  • Angel Touch - Product Description
  • La Fenice Pen - Product Status
  • La Fenice Pen - Product Description
  • La Fenice V - Product Status
  • La Fenice V - Product Description
  • Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • MODD Pivot - Product Status
  • MODD Pivot - Product Description
  • NanoDerma Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Intranasal Insulin Delivery Devices Device - Product Status
  • Intranasal Insulin Delivery Devices Device - Product Description
  • nGageIT Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • InsuloSenz - Product Status
  • InsuloSenz - Product Description
  • Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview
  • PassPort Transdermal Basal Insulin Patch - 12 Hours - Product Status
  • PassPort Transdermal Basal Insulin Patch - 12 Hours - Product Description
  • PassPort Transdermal Basal Insulin Patch - 24Hours - Product Status
  • PassPort Transdermal Basal Insulin Patch - 24Hours - Product Description
  • North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
  • Pulsatile Noninvasive Drug Delivery System - Product Status
  • Pulsatile Noninvasive Drug Delivery System - Product Description
  • Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview
  • AERx iDMS - Product Status
  • AERx iDMS - Product Description
  • Ingestible SOMA - Product Status
  • Ingestible SOMA - Product Description
  • LUMI Device - Product Status
  • LUMI Device - Product Description
  • NovoPen 6 - Product Status
  • NovoPen 6 - Product Description
  • NovoPen Echo Plus - Product Status
  • NovoPen Echo Plus - Product Description
  • Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview
  • Nanobot Based Insulin Pumping Device - Product Status
  • Nanobot Based Insulin Pumping Device - Product Description
  • Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Ambulatory Diabetes Pump - Product Status
  • Ambulatory Diabetes Pump - Product Description
  • PhysioLogic Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
  • ThinPump - Product Status
  • ThinPump - Product Description
  • Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
  • TruePatch - Basal Insulin - Product Status
  • TruePatch - Basal Insulin - Product Description
  • TruePatch - Rapid-Acting (Bolus) Insulin - Product Status
  • TruePatch - Rapid-Acting (Bolus) Insulin - Product Description
  • Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview
  • QForma - Product Status
  • QForma - Product Description
  • Sanofi Pipeline Products & Ongoing Clinical Trials Overview
  • Fix-Flex Device - Product Status
  • Fix-Flex Device - Product Description
  • SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Dual ePump - Product Status
  • Dual ePump - Product Description
  • Open-Protocol Patch Pump System - Product Status
  • Open-Protocol Patch Pump System - Product Description
  • PANDA - Product Status
  • PANDA - Product Description
  • Pod Automated Insulin Delivery Devices Device - Product Status
  • Pod Automated Insulin Delivery Devices Device - Product Description
  • Sooil Development Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Dana-I Pump - Product Status
  • Dana-I Pump - Product Description
  • Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Spring Zone Hybrid Patch Pump - Product Status
  • Spring Zone Hybrid Patch Pump - Product Description
  • Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
  • t:sport - Product Status
  • t:sport - Product Description
  • Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Insulin Patch - Product Status
  • Insulin Patch - Product Description
  • Stabilized and Ultra-Rapid Insulin Pump - Product Status
  • Stabilized and Ultra-Rapid Insulin Pump - Product Description
  • StampPump - Product Status
  • StampPump - Product Description
  • Ultra-Rapid Highly-Concentrated Insulin Pump - Product Status
  • Ultra-Rapid Highly-Concentrated Insulin Pump - Product Description
  • Transdermal Specialties Inc Pipeline Products & Ongoing Clinical Trials Overview
  • U-Strip Insulin Patch - Product Status
  • U-Strip Insulin Patch - Product Description
  • Triple Jump Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Insulin Patch Pump - Product Status
  • Insulin Patch Pump - Product Description
  • University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview
  • Pectin Insulin Gel Skin Patch - Product Status
  • Pectin Insulin Gel Skin Patch - Product Description
  • University of Missouri-Kansas City Pipeline Products & Ongoing Clinical Trials Overview
  • Light Activated Insulin Depot - Product Status
  • Light Activated Insulin Depot - Product Description
  • University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview
  • Smart Cell Patch - Product Status
  • Smart Cell Patch - Product Description
  • Smart Insulin Patch - Product Status
  • Smart Insulin Patch - Product Description
  • University of Toronto Pipeline Products & Ongoing Clinical Trials Overview
  • Implantable Closed-Loop Insulin Delivery Devices Device - Product Status
  • Implantable Closed-Loop Insulin Delivery Devices Device - Product Description
  • Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Wearable Insulin Patch Pump - Product Status
  • Wearable Insulin Patch Pump - Product Description
  • Valeritas Inc Pipeline Products & Ongoing Clinical Trials Overview
  • V-Go Prefill Device - Product Status
  • V-Go Prefill Device - Product Description
  • V-Go SIM - Product Status
  • V-Go SIM - Product Description
  • ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview
  • Kaleido Insulin Pump - Product Status
  • Kaleido Insulin Pump - Product Description
  • Kaleido Insulin Pump - Children And Adolescent - Product Status
  • Kaleido Insulin Pump - Children And Adolescent - Product Description
  • Vigmed Holding AB Pipeline Products & Ongoing Clinical Trials Overview
  • Insulin Needles - Product Status
  • Insulin Needles - Product Description
  • Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
  • Lanzi - Product Status
  • Lanzi - Product Description
  • mylife YpsoPod Insulin Pump - Tubeless - Product Status
  • mylife YpsoPod Insulin Pump - Tubeless - Product Description
  • mylife YpsoPump - Product Status
  • mylife YpsoPump - Product Description
  • Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview
  • HypoPal Rescue Pen - Product Status
  • HypoPal Rescue Pen - Product Description
  • V-Go Wearable Insulin Delivery Devices Device - Product Status
  • V-Go Wearable Insulin Delivery Devices Device - Product Description
  • Zealand Pharma AS - Ongoing Clinical Trials Overview
  • V-Go Wearable Insulin Delivery Devices Device - Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward
  • Zenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Smart Insulin Patch - Product Status
  • Smart Insulin Patch - Product Description
  • Glossary

List of Figures
  • Insulin Delivery Devices - Pipeline Products by Stage of Development
  • Insulin Delivery Devices - Pipeline Products by Segment
  • Insulin Delivery Devices - Pipeline Products by Territory
  • Insulin Delivery Devices - Pipeline Products by Regulatory Path
  • Insulin Delivery Devices - Pipeline Products by Estimated Approval Date
  • Insulin Delivery Devices - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Diabetes Care Inc
  • Aerami Therapeutics Inc
  • Amrita Vishwa Vidyapeetham
  • Andain, Inc
  • Animas Corp
  • ASTI Corp
  • Avecho Biotechnology Ltd
  • Becton Dickinson and Co
  • Bigfoot Biomedical Inc
  • Biocon Ltd
  • Cambridge Consultants Ltd
  • Capillary Biomedical, Inc.
  • Cellnovo Ltd
  • CeQur SA
  • Debiotech SA
  • Defymed SAS
  • Dermisonics Inc (Inactive)
  • Eli Lilly and Co
  • Emperra GmbH E-Health Technologies
  • Hospira Inc
  • Imagine Medical Device Inc.
  • InsuLenz
  • Insulet Corp
  • InsuLine Medical Ltd
  • Iowa State University
  • LifeScan Inc
  • MannKind Corp
  • Medical International Technologies (Mit Canada) Inc
  • Medicsensors SL
  • MedPro Safety Products, Inc.
  • MedSolve Technologies, Inc.
  • Medtronic Diabetes
  • Medtronic Plc
  • MicroPort Scientific Corp
  • Modular Medical Inc
  • NanoDerma Ltd
  • nGageIT Digital Health Inc
  • Nitto Denko Corp
  • North Carolina State University
  • Novo Nordisk AS
  • Pennsylvania State University
  • Phluid Corporation
  • PhysioLogic Devices Inc
  • Prometheon Pharma LLC
  • Qlibrium Inc
  • Sanofi
  • SFC Fluidics LLC
  • Sooil Development Co., Ltd.
  • Spring Health Solutions Ltd.
  • Tandem Diabetes Care Inc
  • Thermalin Inc
  • Transdermal Specialties Inc
  • Triple Jump Israel Ltd
  • University of KwaZulu-Natal
  • University of Missouri-Kansas City
  • University of North Carolina
  • University of Toronto
  • Univlabs Technologies Pvt Ltd
  • Valeritas Inc
  • ViCentra BV
  • Vigmed Holding AB
  • Ypsomed Holding AG
  • Zealand Pharma AS
  • Zenomics Inc

Related Topics

Related Reports

Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 216 Pages
  • Global
From
Insulin Delivery Devices Market - Forecasts from 2024 to 2029 - Product Image

Insulin Delivery Devices Market - Forecasts from 2024 to 2029

  • Report
  • 145 Pages
  • Global
From
Insulin Delivery Device - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Insulin Delivery Device - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Insulin Delivery Devices Market Report 2024 - Product Image

Insulin Delivery Devices Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.